Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: an emerging modality for treating breast cancer

Fig. 3

In vitro release profile of DOX and DTX from polymeric micelles formulation. A, C release of DOX in single and combination form of polymeric micelles, (B, D) release of DTX in single and combination form of formulation at pHs of 7.4 and 5.5 at 37 ℃ under sterile condition. The results represented as the mean ± SD (n = 3)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us